Sandhill Dialysis in Socorro, New Mexico - Dialysis Center

Sandhill Dialysis is a medicare approved dialysis facility center in Socorro, New Mexico and it has 7 dialysis stations. It is located in Socorro county at 1300 Enterprise Rd, Socorro, NM, 87801. You can reach out to the office of Sandhill Dialysis at (505) 835-2045. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Sandhill Dialysis has the following ownership type - Profit. It was first certified by medicare in March, 2017. The medicare id for this facility is 322552 and it accepts patients under medicare ESRD program.

Name	Sandhill Dialysis
Location	1300 Enterprise Rd, Socorro, New Mexico
No. of Dialysis Stations	7
Medicare ID	322552
Managed By	Fresenius Medical Care
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Sandhill Dialysis from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

Dialysis patients with Hemoglobin data

4

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	9
  Adult patient months included in Kt/V greater than or equal to 1.2	41
  Percentage of adult patients getting regular hemodialysis at the center
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Sandhill Dialysis with elevated calcium levels.

Patients with hypercalcemia	9
Hypercalcemia patient months	41
Hypercalcemia patients with serumcalcium greater than 10.2 mg
Patients with Serumphosphor	8
Patients with Serumphosphor less than 3.5 mg/dL
Patients with Serumphosphor from 3.5 to 4.5 mg/dL
Patients with Serumphosphor from 4.6 to 5.5 mg/dL
Patients with Serumphosphor from 5.6 to 7 mg/dL
Patients with Serumphosphor greater than 7 mg/dL

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	16
Patient months included in arterial venous fistula and catheter summaries	52
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	79
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	8